The JUPITER trial finds those with elevated CRP but normal LDL cholesterol benefit from statins.
Comments Off
Comparative-effectiveness advocates want a national entity to evaluate medical treatments against each other. Whether to compare costs is a key question.
Comments Off
Some doctors said the decision could discourage Medicare contractors from using the cost-control measure. CMS did not say whether it would appeal.
Comments Off
The Supreme Court will decide whether federal law preempts product liability suits at the state level if the warning labels are FDA-approved.
Comments Off
The report says unique identifiers would reduce errors and protect privacy, but privacy watchdogs are not convinced.
Comments Off